First Hawaiian Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

First Hawaiian Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$18K	–	1520
2019 Q1	$18K	Hold	200	–	–	﹤0.01%	1243
2018 Q4	$14K	Hold	200	–	–	﹤0.01%	1380
2018 Q3	$19K	Buy	+200	New	+$19.4K	﹤0.01%	1388

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

First Hawaiian Bank's XBI Position: Q2 2019 in Review

First Hawaiian Bank sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2019, closing a stake of 200 shares — an estimated $18K sold.

First Hawaiian Bank first reported a position in XBI in Q3 2018 and held it in 3 quarters. The position peaked at $19K in Q3 2018. 424 funds tracked by Wall St. Rank hold XBI as of Q2 2019.

First Hawaiian Bank reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2019 after selling out during the quarter.
First Hawaiian Bank sold 200 State Street SPDR S&P Biotech ETF shares in Q2 2019, an estimated $18K.
First Hawaiian Bank first reported a position in State Street SPDR S&P Biotech ETF in Q3 2018 and held it in 3 quarters.
First Hawaiian Bank's State Street SPDR S&P Biotech ETF position peaked at $19K in Q3 2018.
424 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2019.

Based on First Hawaiian Bank's 13F filing for Q2 2019, filed 15 Jul 2019.